Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated?
- 15 February 1995
- Vol. 75 (4) , 1018-1024
- https://doi.org/10.1002/1097-0142(19950215)75:4<1018::aid-cncr2820750418>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The activity of single-agent carboplatin in advanced seminomaEuropean Journal Of Cancer, 1992
- Controversies in the use of diagnostic staging laparotomy and splenectomy in the management of Hodgkin's diseaseAnnals of Oncology, 1992
- Testicular ultrasonography after chemotherapy for germ cell neoplasm: Significance of highly hyperechoic lesionsUrology, 1992
- Persistent Carcinoma in situ of the Testis after Chemotherapy for Advanced Testicular Germ Cell TumoursBritish Journal of Urology, 1990
- Imaging the testis and scrotal structuresClinical Radiology, 1990
- Cisplatin‐based Chemotherapy does not Eliminate the Risk of a Second Testicular CancerBritish Journal of Urology, 1989
- RESIDUAL CARCINOMA-IN-SITU OF CONTRALATERAL TESTIS AFTER CHEMOTHERAPYThe Lancet, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Carcinoma‐in‐situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytomaInternational Journal of Andrology, 1987
- Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients.BMJ, 1986